EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 416 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Editorial

Response to hepatitis B vaccine in patients with non-hepatitis B chronic liver disease

Faruk AĞAN ¹ , Yılmaz ÇOLAKOĞLU ² , Atilla ÖKTEN ³ , Selim BADUR ² , Levent ERDEM ² , Selim GÜREL ⁴ , M. Derya ONUK ³ , Fatih BEŞIŞIK ⁵ , Sabahattin KAYMAKOĞLU ⁶

Author Affiliation(s)

1.

Haydarpaşa Numune Hastanesi Gastroenteroloji Kliniği İstanbul

2.

İstanbul Tıp Fakültesi Gastroenterohepatoloji Bilim Dalı İstanbul

3.

İstanbul Üniversitesi, İstanbul Tıp Fakültesi Gastroenteropatoloji Bilim Dalı ve Patoloji anabilim Dalı, İstanbul

4.

Department of Gastroenterology, Uludağ University, School of Medicine, Bursa

5.

Departments of Gastroenterohepatology, İstanbul University İstanbul Medical Faculty, İstanbul

6.

Department of Gastroenterology, İstanbul University, İstanbul School of Medicine, İstanbul

Turk J Gastroenterol 1997; 8: 148-151

Keywords : chronic liver disease, hepatitis b vaccine.

Read: 1538 Downloads: 1481 Published: 25 July 2019

Volume 8, Issue 2, June 1997

Previous Article

Files